Wheel’s Post

📱#Telehealth adoption has bounced back to a 'new normal' following the Covid-19 boom, revealing opportunities for pharma and medtech companies. However, understanding how to navigate this highly dynamic market and how hybrid care models affect their go-to-market strategies are essential for making moves in this new field. Read about the four critical success factors that pharma and medtech companies need to consider in their telehealth strategy here: pwc.to/4bBqVLD #pharma #medtech

Reimagine patient 🏥care, collaboration 🤝 and innovation 💡 Zoom for Healthcare helps you communicate across the continuum of care, meet patients where they are, and enable your hybrid workforce to stay connected and agile. Did You Know? #1. 9 of the top 10 U.S. hospitals, ranked by U.S News, choose Zoom #2. 7 of the top 10 Global pharmaceutical companies choose Zoom #3. 8 of the 10 largest U.S. health systems choose Zoom Learn more: #telehealth #telemedicine #healthcare #Pharmaceuticals #zoom #zoomhealthcare #zoomforhealth

After the Covid-19 boom #telehealth adoption has rebounded to a “new normal”, uncovering opportunities for pharma and medtech companies. Navigating this dynamic market and understanding how hybrid care models impact their go-to-market strategies are crucial for success in this evolving field. Explore the four critical success factors that pharma and medtech companies must consider in their telehealth strategies here: pwc.to/4bBqVLD #pharma #medtech

After the Covid-19 boom #telehealth adoption has rebounded to a “new normal”, uncovering opportunities for pharma and medtech companies. Navigating this dynamic market and understanding how hybrid care models impact their go-to-market strategies are crucial for success in this evolving field. Explore the four critical success factors that pharma and medtech companies must consider in their telehealth strategies here: pwc.to/4bBqVLD #pharma #medtech

Remote Patient Monitoring Market Worth $207.5 billion by 2028 ☑️𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:https://lnkd.in/dfn4dXW9 The size of global remote patient monitoring market in terms of revenue was estimated to be worth $71.9 billion in 2023 and is poised to reach $207.5 billion by 2028, growing at a CAGR of 23.6% from 2023 to 2028 🔵𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Philips Medtronic GE HealthCare Cerner Corporation Siemens Healthineers OMRON Healthcare EMEA Boston Scientific Abbott Vivify Health® Preventice Solutions Biobeat VitalConnect Welch Allyn Teladoc Health Dexcom iRhythm Technologies, Inc. HealthBeats® STARLING MEDICAL PRACTICE, LLC AliveCor Aktiia TytoCare

Integrating technology into pharmacies has streamlined processes and enhanced patient care and outcomes. Pharmacogenomics, automation, telehealth, and data analytics are among the key elements revolutionizing the industry.    Drug Topics highlights the profound changes technology has brought to the pharmacy landscape: https://lnkd.in/ep6Wdj7w.     #PharmacyTech #HealthTech #PharmacyInnovation #HealthcareTechnology 

There is a lot of talk about direct-to-patient models for pharma companies using telehealth (like LillyDirect). But what other opportunities does telehealth offer for pharma and medical device companies in their go-to-market or to improve patient care? Here are some of the highlights: Key opportunities: - Create awareness and reduce drop-off (e.g. like lillydirect) - Bundle medication and delivery with your therapy - Engage and educate HCPs through a telehealth partner - Provide patient support with digital technologies Key considerations - Get the portfolio fit right: You need to match the telehealth opportunity to the unique challenge of your patient population - Localize the strategy: telehealth is too fragmented for a one-fits-all approach (see the blog post for market archetypes) - Know your partner: Exits like Babilon Health showed how dynamic the market is, and your telehealth strategy needs to account for this - Stay clear of the grey zone: It is critical to avoid any actual or perceived conflicts of interest between different healthcare stakeholders Find our more here in our post: pwc.to/4bBqVLD Jonathan Sander, PhD, MBA Mylène Jeandupeux Catijn Schierbeek

Today's Feb 29 webinar helps you understand how to engage with HCPs using a data driven approach that is meaningful for your brand #leadership

Transforming Healthcare through Digital #Therapeutics The healthcare landscape is evolving, and digital therapeutics are revolutionizing #patient care! What are Digital Therapeutics? Digital therapeutics are evidence-based, software-driven interventions that prevent, manage, or treat medical conditions. Benefits: 1. Personalized treatment plans 2. Enhanced patient engagement 3. Improved health outcomes 4. Reduced healthcare costs 5. Increased accessibility The #healthcare landscape is undergoing a significant shift, and digital #therapeutics are at the forefront of this revolution. These evidence-based, software-driven interventions are designed to prevent, manage, or treat #medical conditions, offering personalized treatment plans, enhanced patient engagement, and improved health outcomes. Digital therapeutics focus on areas such as #mentalhealth, #chronicdiseasemanagement, #painmanagement, #addictiontreatment, and #rarediseasemanagement. Successful development requires #clinical validation, regulatory compliance, user-centered design, and robust data analytics. As the digital therapeutics market continues to grow, we're excited to be part of this transformative journey. By leveraging technology and innovation, we can increase accessibility, reduce healthcare costs, and improve patient lives. What are your thoughts on digital therapeutics? Share your insights and let's shape the future of healthcare together! #DigitalTherapeutics #HealthcareTransformation #Innovation #MentalHealth #ChronicDiseaseManagement #HealthTech #DigitalHealth #Wellness #healthcare #marketresearch #Asiamonitor 

Remote Patient Monitoring Market | Grows at CAGR of 20.1% by 2028 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞-https://lnkd.in/dvkxQ4Rj The global remote patient monitoring market in terms of revenue was estimated to be worth $14.0 billion in 2023 and is poised to reach $41.7 billion by 2028, growing at a CAGR of 20.1% from 2023 to 2028. Medtronic GE HealthCare Cerner Corporation Siemens Healthineers OMRON Healthcare Europe Boston Scientific Abbott Vivify Health® Calsoft Labs - An Alten Group Company Preventice Solutions Biobeat VitalConnect Welch Allyn Teladoc Health Dexcom iRhythm Technologies, Inc. HealthBeats® STARLING MEDICAL PRACTICE, LLC AliveCor Aktiia TytoCare